Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Senescence”

809 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 809 results

Testing effectiveness (Phase 2)Study completedNCT00602797
What this trial is testing

Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
University of Nebraska 20
Large-scale testing (Phase 3)Looking for participantsNCT06998069
What this trial is testing

Head and Neck Cancer Study Project in the Geriatric Population

Who this might be right for
Head and Neck Neoplasms
Brown University 20
Not applicableStudy completedNCT04999085
What this trial is testing

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaDisability Physical+1 more
UNC Lineberger Comprehensive Cancer Center 16
Not applicableLooking for participantsNCT07041320
What this trial is testing

Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)Elderly (People Aged 65 or More)
Anhui Chest Hospital 40
Early research (Phase 1)Study completedNCT05762523
What this trial is testing

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

Who this might be right for
SmallpoxMonkeypoxCowpox+1 more
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 60
Testing effectiveness (Phase 2)Study completedNCT02012088
What this trial is testing

Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb

Who this might be right for
Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 91
Testing effectiveness (Phase 2)Study completedNCT01288573
What this trial is testing

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Who this might be right for
Ewing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors
Genzyme, a Sanofi Company 46
Not applicableUnknownNCT03122327
What this trial is testing

CGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.

Who this might be right for
Multiple MyelomaComprehensive Geriatric Assessment
Peking Union Medical College Hospital 200
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Testing effectiveness (Phase 2)Study completedNCT00137800
What this trial is testing

Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Dana-Farber Cancer Institute 82
Large-scale testing (Phase 3)UnknownNCT01827605
What this trial is testing

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Who this might be right for
Relapsed Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 159
Testing effectiveness (Phase 2)Study completedNCT03293680
What this trial is testing

Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 83
Not applicableNot Yet RecruitingNCT07643688
What this trial is testing

Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections

Who this might be right for
SARS CoV 2 InfectionRSV InfectionsInfluenza Infection
Fabiana Sherine Ganem dos Santos 150
Post-approval studies (Phase 4)Study completedNCT02532569
What this trial is testing

Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj

Who this might be right for
Japanese Encephalitis
Boryung Pharmaceutical Co., Ltd 94
Large-scale testing (Phase 3)UnknownNCT01532856
What this trial is testing

Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years

Who this might be right for
Multiple Myeloma
Grupo de Estudos Multicentricos em Onco-Hematologia 64
Testing effectiveness (Phase 2)Study completedNCT01011075
What this trial is testing

Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
New Mexico Cancer Research Alliance 34
Not applicableUnknownNCT03098771
What this trial is testing

Peripheral Blood Autologous CD34+ Cell Transplantation Promotes Angiogenesis With Atherosclerotic Ischemia for Elderly

Who this might be right for
Atherosclerotic Ischemic Disease
Qingdao University 20
Post-approval studies (Phase 4)Ended earlyNCT03673332
What this trial is testing

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

Who this might be right for
Advanced or Metastatic MelanomaAdvanced or Metastatic NSCLC
Institut Paoli-Calmettes 40
Large-scale testing (Phase 3)Study completedNCT04560881
What this trial is testing

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

Who this might be right for
COVID-19 Virus Infection
Laboratorio Elea Phoenix S.A. 3,000
Post-approval studies (Phase 4)Looking for participantsNCT06646471
What this trial is testing

PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies

Who this might be right for
Non Small Cell Lung CancerLung Cancer
GFPC Investigation 500
Load More Results